Advanced search
Publication Cover
Expert Review of Pharmacoeconomics & Outcomes Research Volume 5, 2005 - Issue 1
Submit an article Journal homepage
117
Views
12
CrossRef citations to date
0
Altmetric
Review

Provider incentives and prescribing behavior in Europe

Elias Mossialos Professor of Health Policy, London School of Economics, Health and Social Care, London School of Economics and Political Science, Houghton Street, London, WC2A 2AE, UK. [email protected]
,
Tom Walley Professor of Clinical Pharmacology and Director of the UK National Health Technology Assessment Programme, University of Liverpool, Department of Pharmacology and Therapeutics, The Infirmary, 70 Pembroke Place, Liverpool, L69 3GF, UK. [email protected]
&
Caroline Rudisill Research assistant, London School of Economics, Health and Social Care, London School of Economics and Political Science, Houghton Street, London, WC2A 2AE, UK. [email protected]
Pages 81-93 | Published online: 09 Jan 2014

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Konstantin Tachkov, Alexandra Savova, Manoela Manova & Guenka Petrova. (2023) Tackling reimbursement challenges to fair access to medicines – introduction to the topic. Expert Review of Pharmacoeconomics & Outcomes Research 23:6, pages 597-606.
Read now
Pieter Dylst, Arnold Vulto & Steven Simoens. (2014) Analysis of French generic medicines retail market: why the use of generic medicines is limited. Expert Review of Pharmacoeconomics & Outcomes Research 14:6, pages 795-803.
Read now
Pieter Dylst, Arnold Vulto & Steven Simoens. (2013) Demand-side policies to encourage the use of generic medicines: an overview. Expert Review of Pharmacoeconomics & Outcomes Research 13:1, pages 59-72.
Read now

Articles from other publishers (9)

O. Hirsch, M. Schulz, M. Erhart & N. Donner-Banzhoff. (2018) Factors associated with prescribing costs: analysis of a nationwide administrative database. Cost Effectiveness and Resource Allocation 16:1.
Crossref
Minna Matikainen, Leena Olkkonen, Nina Katajavuori, Petri Parvinen & Anne Juppo. (2017) Physicians’ relationship with the pharmaceutical industry and its reflection in introduction of a new drug. International Journal of Pharmaceutical and Healthcare Marketing 11:3, pages 309-326.
Crossref
Arash Rashidian, Amir-Houshang Omidvari, Yasaman Vali, Heidrun Sturm & Andrew D Oxman. (2015) Pharmaceutical policies: effects of financial incentives for prescribers. Cochrane Database of Systematic Reviews 2015:8.
Crossref
Rosa Rodriguez-Monguio. (2015) Capsule Commentary on Goetz et al., The Effect of Charge Display on Cost of Care and Physician Practice Behaviors: A Systematic Review. Journal of General Internal Medicine 30:6, pages 834-834.
Crossref
Pieter Dylst, Arnold Vulto & Steven Simoens. (2011) Where a cheap medicine is not the same as a generic medicine: the Belgian case. Journal of Pharmaceutical Health Services Research 2:3, pages 185-189.
Crossref
Alexandra Prados-Torres, Amaia Calderón-Larrañaga, Antoni Sicras-Mainar, Sebastià March-Llull & Bárbara Oliván-Blázquez. (2009) Pharmaceutical cost control in primary care: opinion and contributions by healthcare professionals. BMC Health Services Research 9:1.
Crossref
David Granlund. (2009) Are private physicians more likely to veto generic substitution of prescribed pharmaceuticals?. Social Science & Medicine 69:11, pages 1643-1650.
Crossref
A. Mason. (2008) New medicines in primary care: a review of influences on general practitioner prescribing. Journal of Clinical Pharmacy and Therapeutics 33:1, pages 1-10.
Crossref
Elias Mossialos & Adam Oliver. (2005) An overview of pharmaceutical policy in four countries: France, Germany, the Netherlands and the United Kingdom. The International Journal of Health Planning and Management 20:4, pages 291-306.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.